Sabatolimab

sabatolimab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sabatolimab, covering 2024-06-11 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS [Phase 2]